Appraisal of the causal effect of plasma caffeine on adiposity, type 2 diabetes, and cardiovascular disease: two sample mendelian randomisation study.

Susanna C LarssonBenjamin WoolfDipender Gill

Published in: BMJ medicine (2023)

Higher plasma caffeine concentrations might reduce adiposity and risk of type 2 diabetes. Further clinical study is warranted to investigate the translational potential of these findings towards reducing the burden of metabolic disease.

Keyphrases

type diabetes
cardiovascular disease
insulin resistance
weight gain
glycemic control
metabolic syndrome
clinical trial
cardiovascular risk factors
body mass index
risk factors
weight loss
double blind